 | Up a level |
Journal Article
Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F., Schmitt, Wolfgang D., Hanusch, Claus, Fasching, Peter A., Luebbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marme, Frederik, Reimer, Toralf, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Sinn, Bruno, V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stoetzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael and Loibl, Sibylle
(2021).
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol., 22 (8).
S. 1151 - 1162.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Sinn, Marianne, Sinn, Bruno, V, Treue, Denise, Keilholz, Ulrich, Damm, Frederik, Schmuck, Rosa, Lohneis, Philipp, Klauschen, Frederick, Striefler, Jana K., Bahra, Marcus, Blaeker, Hendrik, Bischoff, Sven, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Oettle, Helmut, Riess, Hanno, Budczies, Jan and Denkert, Carsten
(2020).
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
Clin. Cancer Res., 26 (14).
S. 3732 - 3740.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265